Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Mirtazapine for Weight Loss in Advanced Cancer
NCT05170919Phase 2Enrolling by invitation
- Sponsor
- Englewood Hospital
- Start
- Jan 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine, mirtazapine in cancer-associated anorexia, unintentional weight loss, sponsored by Englewood Hospital. Started Jan 2022; status: enrolling by invitation.
02
Drugs
olanzapinemirtazapine
03
Conditions
cancer-associated anorexiaunintentional weight loss
Beyond the preview
Go deeper on NCT05170919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05170919.